Cite
HARVARD Citation
van Schaik, I. et al. (2018). Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet neurology. 17 (1), pp. 35-46. [Online].